TESA / IPA Blend
SKU：tesa-ipa-blend
Price：USD 120.00
Product information
This two-peptide blend combines Tesamorelin with Ipamorelin. Their different receptor targets, GHRH-R and GHS-R, provide the rationale for studying them together in growth-hormone-axis research. Separate receptor pathways do not establish the activity of the complete formulation. A combined clinical outcome or guaranteed response should not be inferred from the individual component mechanisms.
Product specifications
- Product Type
- Two-peptide research blend
- Tesamorelin Molecular Weight
- 5135.8 Da
- Ipamorelin Molecular Weight
- 711.86 g/mol
- Form
- Lyophilized powder
- Purity
- ≥99% (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for long-term stability
- Label amount
- 15mg
Analysis report
Tesamorelin/Ipamorelin 12mg/2mg · 12mg · TSIP14-052026-1
Tesamorelin/Ipamorelin 12mg/2mg · 12mg/2mg · TSIP-02172026-J
Research information
Read the full TESA / IPA Blend research monograph
Research overview
This two-peptide blend combines Tesamorelin with Ipamorelin. Their different receptor targets, GHRH-R and GHS-R, provide the rationale for studying them together in growth-hormone-axis research. Separate receptor pathways do not establish the activity of the complete formulation. A combined clinical outcome or guaranteed response should not be inferred from the individual component mechanisms.